Federal Judge Issues Injunction Against Balance of Nature, Ceasing Production – Yes, on November 16, 2023, a federal court in Utah ordered Balance of Nature, a dietary supplement company, to stop producing and selling its products. The order came after the Food and Drug Administration (FDA) accused the company of making false and misleading claims about the benefits of its products.
The FDA alleged that Balance of Nature had been making claims that its products could cure or prevent a variety of diseases, including cancer, heart disease, and diabetes. The agency also said that the company had been violating current good manufacturing practices (cGMP) regulations, which are designed to ensure the safety and quality of dietary supplements.
In addition to ordering the company to stop production and sales, the court also ordered Balance of Nature to destroy all of its existing products and to pay a $3 million fine.
The FDA’s action against Balance of Nature is part of a broader effort by the agency to crack down on companies that make false and misleading claims about their products. The agency has said that it is committed to protecting consumers from being misled about the potential benefits of dietary supplements.
Here are some of the specific allegations that the FDA made against Balance of Nature
- The company claimed that its products could cure or prevent cancer.
- The company claimed that its products could cure or prevent heart disease.
- The company claimed that its products could cure or prevent diabetes.
- The company claimed that its products could cure or prevent asthma.
- The company claimed that its products could cure or prevent COVID-19.
The FDA also alleged that Balance of Nature had been violating cGMP regulations by:
- Failing to have adequate procedures in place to prevent the contamination of its products.
- Failing to properly test its products to ensure that they met safety and quality standards.
- Failing to keep proper records of its manufacturing processes.
The FDA’s actions against Balance of Nature are a reminder that consumers should be cautious when taking dietary supplements. It is important to talk to a doctor before taking any new supplement, and to only purchase supplements from reputable companies.
Consumers can report any problems they have with dietary supplements to the FDA’s MedWatch program.
Why is the FDA ordering a cease in production?
The FDA orders a cease in production for various reasons, including:
Safety Concerns: If the FDA has reason to believe that a product is unsafe, it may order a cease in production to protect public health. This could be due to contamination, improper manufacturing practices, or other factors that could pose a risk to consumers.
Violation of Regulations: If a company is found to be violating the FD&C Act or other relevant regulations, the FDA may order a cease in production to ensure that the company complies with the law. This could include violations of cGMP regulations, labeling requirements, or other regulatory standards.
False or Misleading Claims: If a company is making false or misleading claims about its products, the FDA may order a cease in production to prevent consumers from being misled. This could include claims that the product can cure or prevent a disease, or that it has benefits that it does not actually have.
In the case of Balance of Nature, the FDA ordered a cease in production due to violations of cGMP regulations and false and misleading claims about the company’s products. The company was accused of failing to follow proper manufacturing procedures, making unsubstantiated claims about the benefits of its products, and lacking adequate testing and recordkeeping.
The FDA’s actions are intended to protect consumers from unsafe and ineffective products. By ordering a cease in production, the agency can prevent further harm to consumers and ensure that companies are held accountable for their actions.
What’s the way forward for Evig and Premium Production?
The consent decrees for Evig LLC and Premium Production require the companies to take several steps to come into compliance with the Federal Food, Drug, and Cosmetic Act (FD&C Act). These steps include:
- Hiring CGMP experts: Both companies must hire qualified cGMP experts to develop and implement procedures to ensure that their products are manufactured in accordance with cGMP regulations.
- Submitting compliance documents: The companies must submit to the FDA a comprehensive set of compliance documents, including detailed manufacturing procedures, quality control protocols, and testing results.
- Obtaining FDA approval: Once the companies have submitted their compliance documents, they must obtain FDA approval before they can resume production and distribution of their products.
In addition to these general requirements, Evig LLC must also take the following steps:
- Employing a labeling expert: The company must hire a labeling expert to review and revise its product labels to ensure that they are accurate and compliant with the FD&C Act.
- Recalling certain products: The company must recall certain of its products that have been found to be adulterated or misbranded.
The companies are prohibited from producing or selling their products until they have completed these actions.
The FDA’s actions against Evig LLC and Premium Production are a reminder that companies that manufacture and market dietary supplements must comply with the FD&C Act. The agency is committed to protecting consumers from unsafe and ineffective dietary supplements.
Takeaway
The FDA has ordered Balance of Nature, a dietary supplement company, to stop production and sales of its products due to false and misleading claims about the benefits of its products and violations of cGMP regulations.
The company is required to destroy all existing products and pay a $3 million fine.
The FDA is committed to protecting consumers from unsafe and ineffective dietary supplements.
Companies that manufacture and market dietary supplements must comply with the Federal Food, Drug, and Cosmetic Act (FD&C Act).
Continue to check our website for more articles of this kind. And, please use our comment section as well, we would love to hear from you.
